Indegene Limited (NSE:INDGN)
India · Delayed Price · Currency is INR 477.90
-18.65 (-3.76%)
At close: Jan 19, 2026
Indegene Market Cap
Indegene has a market cap or net worth of 119.18 billion as of January 16, 2026. Its market cap has decreased by -17.12% in one year.
Market Cap
119.18B
Enterprise Value
107.71B
Revenue
30.41B
Ranking
n/a
PE Ratio
26.85
Stock Price
477.90
Market Cap Chart
Since May 9, 2024, Indegene's market cap has increased from 108.15B to 119.18B, an increase of 10.20%. That is a compound annual growth rate of 5.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 119.18B | -4.59% |
| Dec 31, 2025 | 124.91B | -13.52% |
| Dec 31, 2024 | 144.45B | 33.56% |
| May 9, 2024 | 108.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.00T |
| Divi's Laboratories | 1.66T |
| Cipla | 1.13T |
| Apollo Hospitals Enterprise | 1.04T |
| Mankind Pharma | 898.02B |
| Zydus Lifesciences | 873.51B |
| Alkem Laboratories | 697.84B |
| Aurobindo Pharma | 681.11B |